Learn about common triggers for rheumatoid arthritis flares, including environmental, physiological, and emotional factors, ...

Objectives Treatment of rheumatoid arthritis (RA) relies on immunomodulatory drugs that can compromise immunity, inducing secondary immunodeficiency (SID). However, features of SID, such as ...

If approved, upadacitinib is expected to be the first systemic medication for patients with non-segmental vitiligo, addressing important treatment needs ...

This joint-specific response pattern was consistent across all advanced treatment modalities, including abatacept, interleukin-6 receptor inhibitors, Janus kinase inhibitors, rituximab and TNFi.

Rheumatoid Arthritis : Review in-depth clinical information, latest medical news, and guidelines on rheumatoid arthritis. Read about managing rheumatoid arthritis through diet and latest treatments.

Correspondence to Dr Rishi J Desai, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, Massachusetts, USA; RDESAI{at}BWH.HARVARD.EDU Objectives Recent ...

GLP-1 receptor agonists, particularly new generation agents such as semaglutide and tirzepatide, may significantly reduce the ...

Injured victims of a bus crash rest after receiving initial treatment at a hospital, in Dana Sar, a remote area near the border of Balochistan and Khyber Pakhtunkhwa provinces, in ...

In patients with autoimmune disease prescribed Xiidra, the most common form of dry eye disease was aqueous tear deficiency, and cataracts were common, according to a study presented at Optometry’s ...

Positive CHMP opinion is supported by data from the Phase 3 UP-AA clinical program in which upadacitinib achieved the primary endpoint of Severity of Alopecia Tool (SALT) score = 20 and key ...

Impact and progress Frontiers' impact Our annual reports Thought leadership ...